Search details
1.
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques.
Immunity
; 56(7): 1649-1663.e5, 2023 07 11.
Article
in English
| MEDLINE | ID: mdl-37236188
2.
Drug-induced and malignancy-associated neutrophilic dermatoses in patients with hematologic malignancies: A single institution experience.
Dermatology
; 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38810613
3.
Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant.
Arch Phys Med Rehabil
; 105(6): 1106-1115, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38354878
4.
Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates.
Cytotherapy
; 25(4): 423-431, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36690537
5.
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
Support Care Cancer
; 30(3): 1903-1906, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34741653
6.
Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Xenotransplantation
; 27(4): e12578, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31930750
7.
Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.
Cytotherapy
; 21(7): 725-737, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31085121
8.
Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Am J Hematol
; 94(8): 902-912, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31124175
9.
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Biol Blood Marrow Transplant
; 21(1): 89-96, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25445641
10.
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.
Biol Blood Marrow Transplant
; 21(4): 720-8, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25555450
11.
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Biol Blood Marrow Transplant
; 21(6): 1029-36, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25759146
12.
Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines.
Transplant Cell Ther
; 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38663768
13.
Frailty and Preoperative Palliative Care in Surgical Oncology.
Curr Probl Cancer
; 47(5): 101021, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37865539
14.
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
Blood Adv
; 7(9): 1899-1909, 2023 05 09.
Article
in English
| MEDLINE | ID: mdl-36441905
15.
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.
Transplant Cell Ther
; 28(8): 487.e1-487.e7, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35609865
16.
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.
Lancet Haematol
; 9(1): e14-e25, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34971577
17.
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Transplant Cell Ther
; 27(8): 662.e1-662.e9, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33901720
18.
Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.
Biol Blood Marrow Transplant
; 16(2): 192-8, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19781656
19.
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease.
Blood Adv
; 4(8): 1656-1669, 2020 04 28.
Article
in English
| MEDLINE | ID: mdl-32324888
20.
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.
Hematol Oncol Stem Cell Ther
; 12(2): 105-109, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30836091